Cold Sore |
Cold Sores; Herpes Simplex Virus |
Clinical Trial: Echinacea Versus Placebo Effect in Common Cold
This study is currently recruiting patients.
|
Purpose
The design and interpretation of randomized trials is intimately connected to the use of “placebo”. The nature and magnitude of placebo effects, however, is very poorly understood. This study will assess and compare placebo effects and physician interaction effects within a community-acquired common cold model. The goal of this study is to assess two kinds of placebo affects and how physician interaction effects; a. The effect of receiving blinded placebo, compared to no treatment; and b. The effect of receiving open-label active Echinacea treatment compared to blinded active treatment.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Common Cold | Drug: Echinacea | Phase III |
MedlinePlus related topics: Common Cold
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: The Placebo Effect in Clinical Practice
Expected Total Enrollment: 800
Study start: September 2003; Expected completion: December 2006
Eligibility
Ages Eligible for Study: 12 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
- Suspected or known cold
- At least one of the following cold symptoms: nasal discharge, nasal congestion, sneezing, or sore throat
- Enrolled in school, for children 12 to 17 years of age
Exclusion criteria:
- Pregnancy;
- Symptom duration > 36 hrs
- Concurrent use of antibiotics, antivirals, nasal steroids, decongestants or antihistamines;
- Anticipated need for symptom-relieving meds during cold
- Autoimmune/deficiency disease
- History of allergic rhinitis with current eye itching/sneezing
- History of asthma w/current cough/SOB
- Prior study entry
- Allergy to Echinacea
Location and Contact Information
Wisconsin
University of Wisconsin-Madison Department of Family Medicine, Madison, Wisconsin, 53706-1490, United States; Recruiting
Rob Maberry 608-265-9041 rmaberry@fammed.wisc.edu
Bruce Barrett, MS, MD, PhD, Principal Investigator
More Information
http://www.fammed.wisc.edu
Record last reviewed: October 2004
Last Updated: October 13, 2004
Record first received: July 31, 2003
ClinicalTrials.gov Identifier: NCT00065715
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


